Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 22, 2016 ) Publisher's, 'Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2016', provides an overview of the Leishmaniasis (Kala-Azar) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Leishmaniasis (Kala-Azar),...
Source: EmailWire.com
(Medical-NewsWire.com, November 22, 2016 ) " Low Back Pain-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Low Back Pain. The DelveInsight'sReport covers the product profiles in various stages of development including...
Source: EmailWire.com
(Medical-NewsWire.com, November 22, 2016 ) Publisher's, "Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists. The Publisher's...
Source: EmailWire.com
(Medical-NewsWire.com, November 22, 2016 ) " Renal Osteodystrophy-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Renal Osteodystrophy. The DelveInsight'sReport covers the product profiles in various stages of development...
Source: EmailWire.com
(Medical-NewsWire.com, November 22, 2016 ) " Primary Biliary Cirrhosis-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Primary Biliary Cirrhosis. The DelveInsight'sReport covers the product profiles in various stages of...
Source: EmailWire.com
(Medical-NewsWire.com, November 21, 2016 ) Publisher's, "VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the VCAM-1 (vascular cell adhesion molecule-1) gene...
Source: EmailWire.com
(Medical-NewsWire.com, November 21, 2016 ) Publisher's, "Sphingosine 1-Phosphate Type 1 (S1P-1) Receptor Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Sphingosine 1-Phosphate Type 1 (S1P-1) Receptor Agonists....
Source: EmailWire.com
(Medical-NewsWire.com, November 21, 2016 ) "Spasticity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Spasticity...
Source: EmailWire.com
(Medical-NewsWire.com, November 21, 2016 ) Publisher's, "Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Rho Kinase (Rho-Associated Coiled-Coil...
Source: EmailWire.com
(Medical-NewsWire.com, November 21, 2016 ) " Neuroendocrine Carcinoma-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Neuroendocrine Carcinoma. The DelveInsight'sReport covers the product profiles in various stages of...
Source: EmailWire.com
(Medical-NewsWire.com, November 21, 2016 ) "Myasthenia Gravis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the...
Source: EmailWire.com
(Medical-NewsWire.com, November 21, 2016 ) " Mixed Dyslipidemia-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Mixed Dyslipidemia. The DelveInsight'sReport covers the product profiles in various stages of development...
Source: EmailWire.com
(Medical-NewsWire.com, November 21, 2016 ) " Lysosomal Storage Disorder-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Lysosomal Storage Disorder. The DelveInsight'sReport covers the product profiles in various stages...
Source: EmailWire.com
(Medical-NewsWire.com, November 21, 2016 ) " Japanese Encephalitis-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Japanese Encephalitis. The DelveInsight'sReport covers the product profiles in various stages of development...
Source: EmailWire.com
(Medical-NewsWire.com, November 22, 2016 ) The global excimer and femtosecond ophthalmic lasers market is expected to witness stable growth in 2016, reaching a value of US$ 666 Mn in terms of revenues. Excimer laser systems will continue to outsell femtosecond lasers. North America will remain the...
Source: EmailWire.com
|
|
|
|